Genetic testing for chronic myeloid leukemia (CML) can tell doctors if someone has leukemia, what type they may have, and whether treatment is working. The tests look for atypical changes in certain ...

When the Human Genome Project concluded 21 years ago, it opened the door for genetic testing and a promise for lifesaving screenings and personalized medicine. An innovation that serves as a key ...

Genetic variants that cause rare disorders may remain elusive even after expansive testing, such as exome sequencing. The diagnostic yield of genome sequencing, particularly after a negative ...

Mystery infections—persistent and unexplained illnesses—are a rising global health challenge, often delaying critical treatment as patients and clinicians search for answers. Today, advanced genetic ...

Implementation of and Systems-Level Barriers to Guideline-Driven Germline Genetic Evaluation in the Care of Patients With Myelodysplastic Syndrome and Acute Myeloid Leukemia Somatic and germline ...

Germline genetic testing for patients with gynecologic cancers can be conducted in parallel with tumor somatic testing via a targeted sequencing assay by primary oncologists, researchers reported.

Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces side effects, particularly for patients on psychiatric and cardiovascular ...

Genetic disorders can occur due to mutations in one gene (monogenic), multiple genes (multifactorial inheritance), and mutation in one or more chromosomes. Point mutations are where one nucleotide in ...

The "Direct-to-Consumer Genetic Testing Market and Technologies" report has been added to ResearchAndMarkets.com's offering. The Direct-to-Consumer Genetic Testing Market was valued at USD 2.3 billion ...